President and CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareMake an AppointmentBillingPatient PortalInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Dan Anderson, Ph.D.

Dr. Anderson has spent the last 10 years developing non-viral gene delivery agents.  These studies have resulted in delivery materials with excellent gene delivery performance in vitro and in vivo.  Products based on these materials have been commercialized specifically to transfect stem cells (Stemfect from Stemgent, Xfect from Clonetech).  He has also spent significant effort towards the in vivo application of DNA and RNA delivery systems, and have demonstrated delivery efficacy in a variety of species, including primates. 

Page last updated: November 28, 2015